continued improvements in nuclear medicine instrumentation along with the development of tumor specific radiopharmaceuticals , as well as agents that have the capability of tracking tumor viability , have changed the orientation of scintigraphic techniques in the evaluation of pulmonary neoplastic processes .
C0027651
tumor
C0027671
neoplastic processes